Biktarvy Cost in 2026: Prices & How to Save

Open the pharmacy receipt for a first fill of Biktarvy and the number can stop you cold: more than $4,000 for a single month of pills. That's not a typo, and you're not the only one staring at it. Biktarvy is one of the most prescribed HIV treatments in the United States, and it's also one of the most expensive routine medications a person can be handed.

Here's what that price actually looks like in 2026, why it's so high, and the cash-pay routes that can bring a month of brand-name Biktarvy down to roughly a third of the US retail price.

How much does Biktarvy cost without insurance in 2026?

Biktarvy's manufacturer, Gilead, sets the list price at $4,216 per month. That's the sticker figure the price is anchored to, and it's why an uninsured cash payer at a typical US chain pharmacy sees somewhere between $3,800 and $5,280 for 30 tablets, depending on the pharmacy and location.

Discount services like GoodRx and SingleCare help a little, but not dramatically — they generally land the cash price in the $3,870 to $4,120 range. On a drug this expensive, shaving a few hundred dollars off still leaves a bill most people can't absorb month after month. Over a full year, US retail Biktarvy runs north of $50,000.

Cash-pay pricing through a licensed international pharmacy tells a different story. The same brand-name Biktarvy (50 mg/200 mg/25 mg tablets) is listed through Biktarvy on CanAmerica Plus at $1,413.99 for a 30-tablet supply — a difference of roughly $2,000 a month against a typical US cash price.

Where you buy it	Approx. cash price (30 tablets)
Gilead list price	~$4,216/month
US retail pharmacy (cash)	$3,800 – $5,280/month
US discount card (GoodRx/SingleCare)	~$3,870 – $4,120/month
Licensed cash-pay network (CanAmerica Plus)	$1,413.99/month

Prices shift over time and by pharmacy, so treat these as a snapshot for mid-2026 rather than a fixed quote.

Why is Biktarvy so expensive?

Three things stack up.

First, Biktarvy is brand-only. When a drug has no generic competition, the manufacturer sets the price with no rival version to undercut it. Gilead has raised Biktarvy's list price repeatedly since its 2018 launch.

Second, it's a complete single-tablet regimen. Biktarvy packs three antiretrovirals — bictegravir, emtricitabine, and tenofovir alafenamide — into one daily pill. Convenience and strong clinical results made it the most-prescribed HIV treatment in the country, and that dominant market position gives Gilead little reason to discount.

Third, HIV therapy is lifelong. Because people stay on treatment indefinitely, a high monthly price compounds into an enormous lifetime cost — and it keeps the drug near the top of every "most expensive medications" list.

Is there a generic for Biktarvy?

Not in the US, and not soon.

Biktarvy is protected by a thicket of patents, some running into the mid-2030s. Gilead has also reached settlement agreements with generic drugmakers — including Lupin, Cipla, and Laurus Labs — that delay any US generic launch until 2036. A handful of the underlying patents stretch to late 2036.

So the "wait for the generic" strategy that works for many brand drugs doesn't help here. Anyone paying for Biktarvy today is looking at roughly another decade before a cheaper copycat could reach US shelves — which makes the cash-pay price gap the practical lever, not the patent calendar.

What is Biktarvy, and how does it work?

Biktarvy treats HIV-1 in adults and in children who weigh at least 55 pounds (25 kg). It doesn't cure HIV. What it does is suppress the virus so effectively that, for most people who take it consistently, the amount of HIV in the blood drops to undetectable levels — which protects the immune system and, when maintained, means the virus can't be transmitted to sexual partners.

The three ingredients work in tandem. Bictegravir is an integrase inhibitor that blocks HIV from splicing its genetic material into your cells. Emtricitabine and tenofovir alafenamide are nucleoside/nucleotide reverse transcriptase inhibitors that stop the virus from copying itself. One tablet, once a day, with or without food.

That single-pill simplicity is a big part of why prescribers reach for it — and, again, part of why it's priced the way it is.

How to save on Biktarvy

The uncomfortable truth about most "how to save on Biktarvy" advice online is that it assumes you'll qualify for a program that erases the bill. Plenty of people don't — their income sits just above a cutoff, they're between insurance plans, or they simply want to pay cash and keep the transaction private. If that's you, here's what actually moves the number.

Compare cash prices at licensed pharmacies — including international ones

This is the single biggest lever for the uninsured. Brand-name Biktarvy sold through licensed pharmacies in countries with regulated drug pricing costs a fraction of the US figure. A cash-pay network like CanAmerica Plus connects US patients to that pricing — $1,413.99 for a 30-tablet supply versus a US cash price several times higher. Same 50 mg/200 mg/25 mg brand tablets, a valid prescription required either way.

Before ordering from any international or online pharmacy, confirm it's licensed and verified. Look for a required prescription (any pharmacy that skips that step is a red flag), real pharmacist contact information, and third-party verification.

Use a discount card as a fallback

If you're filling at a US pharmacy, a free discount card from GoodRx or SingleCare is worth running before you pay. On Biktarvy the savings are modest — often landing around $3,900 — but it beats the full sticker price, and there's no cost to check.

Check whether you qualify for public coverage

For HIV specifically, there are government safety-net options worth knowing about. Medicaid covers Biktarvy in most states for people who qualify by income, and every state runs an AIDS Drug Assistance Program (ADAP), funded through the federal Ryan White program, that helps low-income people living with HIV get medication at little or no cost. These are public programs, not something you buy — if your income is low enough, they can be the difference between treatment and no treatment. A local HIV clinic or Ryan White case manager can walk you through eligibility.

Buy a larger day supply

If your prescriber writes for a 90-day supply, filling three months at once often lowers the per-month cost and cuts down on shipping and dispensing fees. It also reduces the risk of a gap in therapy — which matters more with HIV medication than almost anything else, since consistent daily dosing is what keeps the virus suppressed.

Biktarvy side effects worth knowing

Cost is only half the picture. Biktarvy is generally well tolerated, but no HIV medication is free of risk.

The common side effects are usually mild: diarrhea, nausea, headache, and fatigue, especially in the first weeks. Some people notice weight gain over time.

The serious ones are rarer but matter. Biktarvy can affect the kidneys and liver, and in rare cases cause a dangerous buildup of lactic acid in the blood. If you also have hepatitis B, stopping Biktarvy suddenly can trigger a serious flare — which is one more reason never to pause or switch the medication without your provider's guidance. Certain drugs, including some seizure medications, the tuberculosis drug rifampin, and the supplement St. John's Wort, can interfere with how well Biktarvy works, so keep your prescriber current on everything you take.

Beyond Biktarvy, other HIV medications carry their own price tags and savings math — CanAmerica Plus also lists regimens like Truvada — but which regimen fits is a clinical decision for you and your doctor, never a price-driven one.

The bottom line

Biktarvy costs about $4,216 a month at list price in the US, with no generic on the way before 2036. The people hit hardest are the uninsured and underinsured — and for them, the most reliable savings don't come from waiting or from shaving a few hundred dollars off with a discount card. They come from comparing cash prices across licensed pharmacies, where the same brand-name Biktarvy can run closer to $1,400 a month. Check current pricing on the Biktarvy product page, keep taking it exactly as prescribed, and bring any change you're considering to your provider first.

Frequently asked questions

What is the cost of a 30-day supply of Biktarvy?

At list price, a 30-day supply of Biktarvy is about $4,216. US retail cash prices typically fall between $3,800 and $5,280 depending on the pharmacy. Through a licensed cash-pay network like CanAmerica Plus, a 30-tablet supply is listed at $1,413.99 as of July 2026.

Why is Biktarvy so expensive?

It's a brand-only medication with no generic competition, it combines three antiretrovirals in one single-tablet regimen, and it's taken for life. Those factors, plus repeated list-price increases since its 2018 launch, keep it among the priciest routine medications in the US.

Can I get Biktarvy for free or cheaper?

Some people qualify for public coverage such as Medicaid or their state's AIDS Drug Assistance Program (ADAP), which can cover Biktarvy at little or no cost for those who meet income requirements. If you don't qualify, the next-best move is comparing cash prices across licensed pharmacies — including verified international ones — which can cut the monthly cost to roughly a third of the US retail price.

Is there a generic version of Biktarvy?

No. There is no generic Biktarvy in the US, and patent settlements with generic manufacturers delay any launch until 2036. Until then, the brand-name product is the only option, which is why cash-price comparison is the practical way to save.

Do you have to take Biktarvy forever?

HIV treatment is lifelong. Biktarvy controls the virus but doesn't cure it, so stopping the medication allows HIV to rebound. Consistent daily dosing is what keeps the virus suppressed, so any change should be planned with your provider — not driven by cost alone.

---

This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment. Pricing information is current as of the publication date but may change. Verify pricing directly before making purchasing decisions.